January 16, 2018 / 12:54 PM / 3 months ago

BRIEF-Avexis Announces Expanded Clinical Development Program For AVXS-101 In Spinal Muscular Atrophy

Jan 16 (Reuters) - Avexis Inc:

* AVEXIS ANNOUNCES EXPANDED CLINICAL DEVELOPMENT PROGRAM FOR AVXS-101 IN SPINAL MUSCULAR ATROPHY

* AVEXIS - TO EXPAND STUDY OF AVXS-101 INTO ADDITIONAL SMA POPULATIONS INCLUDING PRE-SYMPTOMATIC, OLDER PEDIATRIC TYPE 2 AND TYPE 3 SMA PATIENTS

* AVEXIS INC - ‍PLANS TO INITIATE THREE STUDIES TO FURTHER EVALUATE AVXS-101, INCLUDING IN NEW SMA PATIENT POPULATIONS​

* AVEXIS INC - ‍EXPECTS TO INITIATE PIVOTAL TRIAL OF AVXS-101 IN SMA TYPE 1 IN EUROPE​ IN FIRST HALF OF 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below